Cantor Fitzgerald Downgrades Obagi Medical Products (OMPI) to Hold; Sees No Competing Bids
Tweet Send to a Friend
Cantor Fitzgerald downgraded Obagi Medical Products (NASDAQ: OMPI) from Buy to Hold with a price target of $19.75 after yesterday's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
